MOTS-C peptide Canada from Maple Research Labs offers 10mg of mitochondrial-derived research peptide with a published COA for a tested sample for qualified investigators.
MOTS-C peptide Canada: a mitochondrial-derived peptide encoded within the 12S rRNA gene of mitochondrial DNA. This research compound is available from Maple Research Labs at 10mg per vial. Published COA for a tested sample (report DBAV-MOTS-10-051226-02) lists 99.69% HPLC-UV relative-area purity for that sample; the report does not establish every vial or current shipping-lot coverage.
Product Specifications
- Sequence Length: 16 amino acids
- Origin: Mitochondrial genome (12S rRNA)
- Molecular Weight: Approximately 2174 Da
- Purity: 99.69% HPLC-UV relative-area on published tested sample (report DBAV-MOTS-10-051226-02). Not a verification of every vial or lot.
- Form: Lyophilized powder
- Quantity: 10mg per vial
MOTS-C Peptide Canada Research Summary
MOTS-C (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino acid peptide discovered in 2015 by Dr. Changhan Lee’s research group at the University of Southern California. It is encoded within the mitochondrial genome, making it one of several mitochondrial-derived peptides (MDPs) identified as potential signaling molecules between mitochondria and the nuclear genome. The MOTS-C peptide Canada product enables researchers to study this retrograde signaling pathway.
MOTS-C is distinguished from other mitochondrial-derived peptides such as humanin and SHLPs by its unique origin within the 12S rRNA gene and its documented effects on cellular metabolism and AMPK pathway activation in published preclinical studies.
Mechanism of Action Research
Research has identified MOTS-C as an activator of the AMPK (AMP-activated protein kinase) signaling pathway, a central regulator of cellular energy homeostasis. Published studies have demonstrated that MOTS-C treatment in cell culture models leads to AMPK phosphorylation, which in turn modulates downstream targets involved in glucose uptake, fatty acid oxidation, and mitochondrial biogenesis.
The proposed mechanism involves MOTS-C’s interference with the folate cycle and de novo purine biosynthesis, leading to accumulation of the AMPK-activating metabolite AICAR (5-aminoimidazole-4-carboxamide ribonucleotide). This metabolic pathway disruption results in indirect AMPK activation rather than direct kinase binding, representing a distinctive mechanism compared to pharmacological AMPK activators.
In vitro studies have also demonstrated that MOTS-C can translocate to the nucleus under conditions of metabolic stress, where it interacts with nuclear DNA and regulates adaptive gene expression. This nuclear translocation represents a novel form of mitochondria-to-nucleus communication that has generated significant research interest in the mitochondrial biology field.
Preclinical Study Summary
Published preclinical studies have examined MOTS-C in the context of metabolic research, exercise physiology models, and aging biology. Animal model investigations have explored its effects on glucose metabolism, insulin sensitivity, and body composition in diet-induced obesity models. The peptide’s role in exercise-induced metabolic adaptations has been studied in rodent exercise protocols.
MOTS-C levels have been reported to decline with age in both rodent and human plasma samples, paralleling observations made with other mitochondrial-derived peptides. This age-related decline has positioned MOTS-C as a compound of interest in geroscience research.
All findings are from preclinical research. Researchers should consult primary sources for protocols.
References
MOTS-C Peptide Canada Quality Assurance
Third-party certificates of analysis for tested samples are published on our COA page. Read the applicable report for its tested compound, size, method and results. Read the applicable report for any reported retention time, method-specific relative-area purity and separately measured content. These results apply to its tested sample. Published sample reports alone do not establish the lot or analysis of a specific supplied vial. Vials do not carry printed lot or batch numbers. Review the individual report for the analyses actually performed. HPLC-UV purity alone does not establish sequence, cyclization, oxidation state or shipping-unit consistency.
Storage and Handling
Store lyophilized at -20C. Avoid freeze-thaw cycles and light.
Shipping
In-stock orders paid by 2 PM PT (Mon–Fri) ship the same business day, from BC with tracking.
Certificate of Analysis (COA)
| Testing Laboratory | Third-party laboratory |
| Report Number | DBAV-MOTS-10-051226-02 |
| Purity (HPLC-UV) | 99.69% |
| Content / Fill Accuracy | 10.82mg measured / 10.00mg expected (108.2%) |
| Date Tested | May 23, 2026 |
| Download COA | Download Full COA (PDF) |
For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.
Related Research Articles
- MOTS-C vs Glutathione: Mitochondrial Research
- NAD+ vs Glutathione: Key Research Compounds in Cellular Studies
- Certificates of Analysis (COA) Documentation
- Browse All Research Peptides
Frequently Asked Questions
What is the CAS number for MOTS-C?
The CAS registry number for MOTS-C is 1627580-64-6. It is a mitochondria-derived peptide encoded by the 12S rRNA gene.
What is MOTS-C purity?
Published COA for a tested sample (report DBAV-MOTS-10-051226-02) lists 99.69% HPLC-UV relative-area purity for that sample. The report does not establish every vial or current shipping-lot coverage.
What research areas involve MOTS-C?
MOTS-C has been studied in the context of metabolic regulation, AMPK pathway activation, insulin sensitivity, and exercise physiology in animal models.
Related Research Peptides from Maple Research
Researchers may also be interested in Tesamorelin 5MG, Retatrutide 10MG. See each product’s available analytical documentation and tested-sample results in the COA index. In-stock orders paid by 2 PM PT (Mon–Fri) ship the same business day, from BC with tracking.
Join the research list
New arrivals, current pricing, and research breakdowns, every few days. Unsubscribe anytime.
Maple 






